Claudia Ruiz

1.4k citations

36 papers · 1.0k indexed · h-index 20

Molecular Biology
Organic Chemistry top 5%
Oncology
Computational Theory and Mathematics top 5%
Pharmacology

Co-authors: Michael D. Cameron Lin Li Philip V. LoGrasso Thomas Schröter Yangbo Feng Marcel Koenig Yuanjun He Yan Yin
Topics: Melanoma and MAPK Pathways (14 papers)Protein Kinase Regulation and GTPase Signaling (12 papers)Synthesis and biological activity (8 papers)
Cited by: Organic Chemistry Molecular Biology Computational Theory and Mathematics
Journals: Journal of Medicinal Chemistry European Journal of Medicinal Chemistry Bioorganic & Medicinal Chemistry
Partner nations: United States China Austria

In The Last Decade

Claudia Ruiz

36 papers receiving 1.0k citations

Peers

Countries citing papers authored by Claudia Ruiz

Since Specialization

Citations

This map shows the geographic impact of Claudia Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudia Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudia Ruiz more than expected).

Fields of papers citing papers by Claudia Ruiz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudia Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudia Ruiz. The network helps show where Claudia Ruiz may publish in the future.

Co-authorship network of co-authors of Claudia Ruiz

This figure shows the co-authorship network connecting the top 25 collaborators of Claudia Ruiz. A scholar is included among the top collaborators of Claudia Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudia Ruiz. Claudia Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents 2023 ·European Journal of Medicinal Chemistry ·(unknown),(unknown),Marina Candido Primi,(unknown),Claudia Ruiz,Thales Kronenberger,Stefan Laufer,Márcia Inês Goettert,Antti Poso,(unknown),(unknown),(unknown),Neuza Mariko Aymoto Hassimotto,Michael D. Cameron,Thomas D. Bannister,Letícia V. Costa‐Lotufo,João Agostinho Machado‐Neto,Maurício T. Tavares,Roberto Parise‐Filho	4
2	Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor 2022 ·Bioorganic & Medicinal Chemistry Letters ·Rita Fuerst,(unknown),Anna M. Knapinska,Michael D. Cameron,Claudia Ruiz,Amber L. Delmas,Mark S. Sundrud,Gregg Fields,William Roush	8
3	Structure–Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production 2021 ·Journal of Medicinal Chemistry ·Hua Lin,Kfir Sharabi,Lin Li,Claudia Ruiz,Di Zhu,Michael D. Cameron,Scott J. Novick,Patrick R. Griffin,Pere Puigserver,Theodore M. Kamenecka	4
4	Development of matrix metalloproteinase-13 inhibitors – A structure-activity/structure-property relationship study 2018 ·Bioorganic & Medicinal Chemistry ·Rita Fuerst,(unknown),Anna M. Knapinska,Lyndsay Smith,Michael D. Cameron,Claudia Ruiz,Gregg Fields,William Roush	17
5	In vivo instability of platensimycin and platencin: Synthesis and biological evaluation of urea- and carbamate-platensimycin 2017 ·Bioorganic & Medicinal Chemistry ·Liao‐Bin Dong,Jeffrey D. Rudolf,Li Lin,Claudia Ruiz,Michael D. Cameron,Ben Shen	23
6	Amino acid derived quinazolines as Rock/PKA inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Sarwat Chowdhury,Yen‐Ting Chen,X. M. Fang,Wayne Grant,Jennifer Pocas,Michael D. Cameron,Claudia Ruiz,Li Lin,HaJeung Park,Thomas Schröter,Thomas D. Bannister,Philip V. LoGrasso,Yangbo Feng	13
7	Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Yuanjun He,Derek R. Duckett,Wei‐Min Chen,Yuan Yuan Ling,Michael D. Cameron,Lin Li,Claudia Ruiz,Philip V. LoGrasso,Theodore M. Kamenecka,Marcel Koenig	19
8	Imidazopyridines as selective CYP3A4 inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Xinyi Song,Xiaohai Li,Claudia Ruiz,Yan Yin,Yangbo Feng,Theodore M. Kamenecka,Michael D. Cameron	5
9	Synthesis and SAR of tetrahydroisoquinolines as Rev-erbα agonists 2012 ·Bioorganic & Medicinal Chemistry Letters ·Romain Noël,Xinyi Song,Youseung Shin,Subhashis Banerjee,Douglas J. Kojetin,Lin Li,Claudia Ruiz,Michael D. Cameron,Thomas P. Burris,Theodore M. Kamenecka	22
10	Small molecule amides as potent ROR-γ selective modulators 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Bahaa Elgendy,Naresh Kumar,Rubén D. Garcia-Ordoñez,Lin Li,Claudia Ruiz,Michael D. Cameron,Patrick R. Griffin,Theodore M. Kamenecka	26
11	Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·X. M. Fang,Yen‐Ting Chen,E. Hampton Sessions,Sarwat Chowdhury,Tomáš Vojkovský,Yan Yin,Jennifer Pocas,Wayne Grant,Thomas Schröter,Lin Li,Claudia Ruiz,Michael D. Cameron,Philip V. LoGrasso,Thomas D. Bannister,Yangbo Feng	27
12	Discovery and optimization of indoles and 7-azaindoles as Rho kinase (ROCK) inhibitors (part-I) 2011 ·Bioorganic & Medicinal Chemistry Letters ·Sarwat Chowdhury,E. Hampton Sessions,Jennifer Pocas,Wayne Grant,Thomas Schröter,Lin Li,Claudia Ruiz,Michael D. Cameron,Stephan C. Schürer,Philip V. LoGrasso,Thomas D. Bannister,Yangbo Feng	38
13	Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease 2011 ·ACS Chemical Neuroscience ·Jeremy W. Chambers,Alok S. Pachori,Shannon Howard,Michelle L. Ganno,(unknown),Ted Kamenecka,Xinyi Song,Derek R. Duckett,Wei‐Min Chen,Yuan Yuan Ling,Lisa Cherry,Michael D. Cameron,Li Lin,Claudia Ruiz,Philip V. LoGrasso	52
14	Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Romain Noël,Youseung Shin,Xinyi Song,Yuanjun He,Marcel Koenig,Wei‐Min Chen,Yuan Yuan Ling,Lin Li,Claudia Ruiz,(unknown),Michael D. Cameron,Derek R. Duckett,Theodore M. Kamenecka	15
15	The development of benzimidazoles as selective rho kinase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·E. Hampton Sessions,Michael Smolinski,Bo Wang,(unknown),Sarwat Chowdhury,Yan Yin,Yen‐Ting Chen,Claudia Ruiz,Lin Li,Jennifer Pocas,Thomas Schröter,Michael D. Cameron,Philip V. LoGrasso,Yangbo Feng,Thomas D. Bannister	20
16	Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Yan Yin,Lin Li,Claudia Ruiz,Michael D. Cameron,Jennifer Pocas,Wayne Grant,Thomas Schröter,Wei‐Min Chen,Derek R. Duckett,Stephan C. Schürer,Philip V. LoGrasso,Yangbo Feng	40
17	Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways 2009 ·Drug Metabolism and Disposition ·Xiaohai Li,Yuanjun He,Claudia Ruiz,Marcel Koenig,Michael D. Cameron	134
18	Benzimidazole- and benzoxazole-based inhibitors of Rho kinase 2008 ·Bioorganic & Medicinal Chemistry Letters ·E. Hampton Sessions,Yan Yin,Thomas D. Bannister,Amiee Weiser,(unknown),Jennifer Pocas,Michael D. Cameron,Claudia Ruiz,Lin Li,Stephan C. Schürer,Thomas Schröter,Philip V. LoGrasso,Yangbo Feng	82
19	Chroman-3-amides as potent Rho kinase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Yen‐Ting Chen,Thomas D. Bannister,Amiee Weiser,(unknown),Lin Li,Claudia Ruiz,Michael D. Cameron,Stephan C. Schürer,Derek R. Duckett,Thomas Schröter,Philip V. LoGrasso,Yangbo Feng	45
20	Structure–activity relationships, and drug metabolism and pharmacokinetic properties for indazole piperazine and indazole piperidine inhibitors of ROCK-II 2006 ·Bioorganic & Medicinal Chemistry Letters ·Yangbo Feng,Michael D. Cameron,(unknown),(unknown),Lin Li,Claudia Ruiz,Thomas Schröter,Philip V. LoGrasso	39

About Claudia Ruiz

Claudia Ruiz is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology, having authored 36 papers that have together received 1.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (14 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Synthesis and biological activity (8 papers). The work is most often cited by research in Organic Chemistry (399 citations), Molecular Biology (616 citations) and Computational Theory and Mathematics (126 citations). Claudia Ruiz has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Michael D. Cameron, Lin Li, Philip V. LoGrasso, Thomas Schröter, Yangbo Feng, Marcel Koenig, Yuanjun He, Yan Yin, Xiaohai Li and Stephan C. Schürer. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact